• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow reports first quarter 2026 results

    4/23/26 6:00:00 AM ET
    $DOW
    Major Chemicals
    Industrials
    Get the next $DOW alert in real time by email

    MIDLAND, Mich., April 23, 2026 /PRNewswire/ -- Dow (NYSE:DOW):

    Dow, Inc. (PRNewsfoto/The Dow Chemical Company)

    FINANCIAL HIGHLIGHTS

    • Net sales were $9.8 billion, down 6% year-over-year, reflecting flat sales in Performance Materials & Coatings and declines in the other operating segments.
    • Volume decreased 2% year-over-year, driven by declines in Industrial Intermediates & Infrastructure, which was impacted by the Middle East conflict. Gains in Packaging & Specialty Plastics from higher polyethylene volumes were more than offset by lower merchant olefins sales following the idling of a cracker in Europe, the Middle East, Africa and India (EMEAI) in mid-2025 and planned maintenance activity in the U.S. Gulf Coast.
    • Local price was down 7% versus the year-ago period.
    • The Company suspended Sadara equity loss recognition in the first quarter of 2026 in accordance with GAAP. The carrying value of all liabilities on the balance sheet reached total existing relevant obligations and commitments.
    • GAAP net loss was $445 million. Op. EBIT1 was $154 million, down $76 million year-over-year. This was primarily driven by lower prices, which were partly offset by tailwinds from the Company's cost reduction program.
    • GAAP loss per share was $0.74; operating earnings per share (EPS)1 was a loss of $0.14, compared to earnings of $0.02 in the year-ago period. Op. EPS excludes significant items totaling $0.60 per share, driven by an adjustment to the Sadara guarantee liability and taxes associated with receipt of payment from NOVA Chemicals related to the Company's ongoing litigation.  
    • Cash provided by operating activities – continuing operations was $1.1 billion, up $1.0 billion year-over-year, primarily driven by receipt of payment from NOVA Chemicals and working capital improvements.  
    • Returns to shareholders totaled $252 million of dividends in the quarter.

    CEO QUOTE

    "In the first quarter, our results reflect the growing impact of Dow's self-help actions. Additionally, the margin backdrop began to positively inflect in March following global supply constraints, as impacts from the conflict in the Middle East quickly became widespread," said Jim Fitterling, Dow chair and CEO. "The strength of Dow's advantaged portfolio is a clear differentiator, enabling us to win in our key end markets. Our unmatched Americas manufacturing footprint, leading European feedstock flexibility and agile global supply chains allow us to continue to innovate and serve our customers safely and reliably through all cycles and macroeconomic conditions. We also remain steadfast in our commitment to Transform to Outperform, which is already becoming a catalyst for growth, productivity and sustained value creation well into the future."

    SUMMARY FINANCIAL RESULTS



    Three Months Ended Mar 31

    In millions, except per share amounts

    1Q26

    1Q25

    vs. SQLY

    [B / (W)]

    Net Sales

    $9,794

    $10,431

    $(637)

    GAAP Income (Loss) Net of Tax

    $(445)

    $(290)

    $(155)

    Operating EBIT¹

    $154

    $230

    $(76)

    Operating EBITDA¹

    $873

    $944

    $(71)

    GAAP Earnings (Loss) Per Share

    $(0.74)

    $(0.44)

    $(0.30)

    Operating Earnings Per Share¹

    $(0.14)

    $0.02

    $(0.16)

    Cash Provided by (Used for) Operating Activities – Cont. Ops

    $1,124

    $104

    $1,020





    1.

    Op. Earnings Per Share, Op. EBIT, Op. EBIT Margin and Op. EBITDA, Free Cash Flow and Cash Flow Conversion are non-GAAP measures. See page 5 for further discussion.

    ®TM Trademark of The Dow Chemical Company or an affiliated company of Dow 

    SEGMENT HIGHLIGHTS

    Packaging & Specialty Plastics



    Three Months Ended Mar 31

    In millions

    1Q26

    1Q25

    vs. SQLY

    [B / (W)]

    Net Sales

    $4,919

    $5,310

    $(391)

    Operating EBIT

    $208

    $342

    $(134)

    Packaging & Specialty Plastics segment net sales in the quarter were $4.9 billion, down 7% versus the year-ago period. Local price decreased 9% year-over-year, primarily driven by lower polyethylene prices. Currency increased net sales by 3%. Volume decreased 1% year-over-year as higher polyethylene volumes in all regions were offset by lower merchant olefins sales and lower licensing revenue.

    Op. EBIT was $208 million, a decrease of $134 million compared to the year-ago period, driven by lower integrated margins and higher planned maintenance activity, partly offset by higher polyethylene volumes that were enabled by our new polyethylene unit in Freeport, Texas and tailwinds from the Company's cost reduction program.

    Packaging and Specialty Plastics business reported a net sales decrease versus the year-ago period, as lower polyethylene prices and lower licensing revenue were partly offset by higher volume in resilient flexible packaging applications.

    Hydrocarbons & Energy business reported a net sales decrease year-over-year, driven by lower merchant olefins sales due to planned maintenance activity in the U.S. Gulf Coast and the idling of a cracker in EMEAI in mid-2025.

    Industrial Intermediates & Infrastructure



    Three Months Ended Mar 31

    In millions

    1Q26

    1Q25

    vs. SQLY

    [B / (W)]

    Net Sales

    $2,626

    $2,855

    $(229)

    Operating EBIT

    $(118)

    $(128)

    $10

    Industrial Intermediates & Infrastructure segment net sales were $2.6 billion, down 8% versus the year-ago period. Local price declined 8% year-over-year, reflecting declines in both businesses. Currency increased net sales by 4%. Volume decreased 4% year-over-year, primarily driven by lower volumes in Polyurethanes & Construction Chemicals, including impacts from the Middle East conflict. 

    Op. EBIT increased $10 million versus the year-ago period, driven by lower planned maintenance activity, the suspension of the recognition of equity losses from Sadara, and tailwinds from the Company's cost reduction program, which were partly offset by lower prices.

    Polyurethanes & Construction Chemicals business reported a decrease in net sales compared to the year-ago period, primarily driven by local price, along with lower volumes from the shutdown of our higher-cost upstream propylene oxide unit in the U.S. Gulf Coast in late 2025, and the Middle East conflict.

    Industrial Solutions business reported a decrease in net sales compared to the year-ago period, as higher volumes from recent alkoxylation investments and increased demand for data center applications were more than offset by lower local prices and lower licensing revenue.

    Performance Materials & Coatings



    Three Months Ended Mar 31

    In millions

    1Q26

    1Q25

    vs. SQLY

    [B / (W)]

    Net Sales

    $2,080

    $2,071

    $9

    Operating EBIT

    $117

    $49

    $68

    Performance Materials & Coatings segment net sales in the quarter were $2.1 billion, flat versus the year-ago period. Local price decreased 4% year-over-year, driven by a decline in Coatings & Performance Monomers. Currency increased net sales by 2%. Volume increased 2% year-over-year, driven by higher volumes in both businesses, led by growth in downstream silicones and acrylic monomers.

    Op. EBIT was $117 million, an increase of $68 million versus the year-ago period. This was driven primarily by volume gains across both businesses and lower fixed costs, including lower planned maintenance activity and tailwinds from the Company's cost reduction program, which were partly offset by lower price.

    Consumer Solutions business reported an increase in net sales versus the year-ago period, driven by currency tailwinds and volume gains in downstream silicones, led by gains in electronics applications globally and home and personal care applications in the U.S. & Canada, which were partially offset by lower local prices.

    Coatings & Performance Monomers business reported a decrease in net sales compared to the year-ago period, as lower prices were partly offset by higher acrylic monomers volume, primarily in the U.S. & Canada.

    OUTLOOK

    "We are already seeing rapid positive momentum from our announced pricing actions in every business and every region, as well as constructive impacts to our operating rates," said Fitterling. "We are leveraging Dow's purpose-built asset footprint, well-established supply chain routes and leading asset reliability to prioritize our customers and navigate the conflict in the Middle East. At the same time, our teams remain focused on capturing growth in attractive markets while delivering cost savings and cash support. Transform to Outperform aims to radically simplify how we operate, reengineer our processes and cost structures and modernize how we serve our customers. These collective actions position the Company for improved growth and productivity, expanded margins, and higher shareholder returns across the cycle."

    Conference Call

    Dow will host a live webcast of its quarterly earnings conference call with investors to discuss its results, business outlook and other matters today at 8:00 a.m. ET. The webcast and slide presentation that accompany the conference call will be posted on the events and presentations page of investors.dow.com.

    About Dow

    Dow (NYSE:DOW) is one of the world's leading materials science companies, serving customers in high-growth markets such as packaging, infrastructure, mobility and consumer applications. Our global breadth, asset integration and scale, customer-focused innovation and leading business positions enable us to achieve profitable growth and help deliver a sustainable future. We operate manufacturing sites in 29 countries and employ approximately 34,600 people. Dow delivered sales of approximately $40 billion in 2025. References to Dow or the Company mean Dow Inc. and its subsidiaries. Learn more about us at www.dow.com.

    X: https://twitter.com/DowNewsroom 

    Facebook: https://www.facebook.com/dow/ 

    LinkedIn: http://www.linkedin.com/company/dow-chemical 

    Instagram: http://instagram.com/dow_official 

     

    Cautionary Statement about Forward-Looking Statements

    Certain statements in this press release are "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements often address expected future business and financial performance, financial condition, and other matters, and often contain words or phrases such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "opportunity," "outlook," "plan," "project," "seek," "should," "strategy," "target," "will," "will be," "will continue," "will likely result," "would" and similar expressions, and variations or negatives of these words or phrases.

    Forward-looking statements are based on current assumptions and expectations of future events that are subject to risks, uncertainties and other factors that are beyond Dow's control, which may cause actual results to differ materially from those projected, anticipated or implied in the forward-looking statements and speak only as of the date the statements were made. These factors include, but are not limited to: sales of Dow's products; Dow's expenses, future revenues and profitability; any supply chain, operational or other disruptions, sanctions, export restrictions, or increased economic uncertainty related to the ongoing conflicts between Russia and Ukraine and in the Middle East; capital requirements and need for and availability of financing; unexpected barriers in the development of technology, including with respect to Dow's contemplated capital and operating projects; Dow's ability to realize its commitment to carbon neutrality on the contemplated timeframe, including the completion and success of its integrated ethylene cracker and derivatives facility in Alberta, Canada; size of the markets for Dow's products and services and ability to compete in such markets; Dow's ability to develop and market new products and optimally manage product life cycles; the rate and degree of market acceptance of Dow's products; significant litigation and environmental matters and related contingencies and unexpected expenses; the success of competing technologies that are or may become available; the ability to protect Dow's intellectual property in the United States and abroad; Dow's ability to realize expected benefits from Transform to Outperform on the contemplated timeframe; developments related to contemplated restructuring activities and proposed divestitures or acquisitions such as workforce reduction, manufacturing facility and/or asset closure and related exit and disposal activities, and the benefits and costs associated with each of the foregoing; fluctuations in energy and raw material prices; management of process safety and product stewardship; changes in relationships with Dow's significant customers and suppliers; changes in public sentiment and political leadership; increased concerns about plastics in the environment and lack of a circular economy for plastics at scale; changes in consumer preferences and demand; changes in laws and regulations, political conditions, tariffs and trade policies, or industry development; global economic and capital markets conditions, such as inflation, market uncertainty, interest and currency exchange rates, and equity and commodity prices; business, logistics, and supply disruptions; security threats, such as acts of sabotage, terrorism or war, including the ongoing conflicts between Russia and Ukraine and in the Middle East; weather events and natural disasters; disruptions in Dow's information technology networks and systems, including the impact of cyberattacks; risks related to Dow's separation from DowDuPont Inc. such as Dow's obligation to indemnify DuPont de Nemours, Inc. and/or Corteva, Inc. for certain liabilities; and any global and regional economic impacts of a pandemic or other public health-related risks and events on Dow's business.

    Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. A detailed discussion of principal risks and uncertainties which may cause actual results and events to differ materially from such forward-looking statements is included in the section titled "Risk Factors" contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2025, and the Company's subsequent reports filed with the U.S. Securities and Exchange Commission. These are not the only risks and uncertainties that Dow faces. There may be other risks and uncertainties that Dow is unable to identify at this time or that Dow does not currently expect to have a material impact on its business. If any of those risks or uncertainties develops into an actual event, it could have a material adverse effect on Dow's business. Dow Inc. and The Dow Chemical Company and its consolidated subsidiaries assume no obligation to update or revise publicly any forward-looking statements whether because of new information, future events, or otherwise, except as required by securities and other applicable laws.

    ®TM Trademark of The Dow Chemical Company or an affiliated company of Dow                 

    Non-GAAP Financial Measures

    This earnings release includes information that does not conform to GAAP and are considered non-GAAP measures. Management uses these measures internally for planning, forecasting and evaluating the performance of the Company's segments, including allocating resources. Dow's management believes that these non-GAAP measures best reflect the ongoing performance of the Company during the periods presented and provide more relevant and meaningful information to investors as they provide insight with respect to ongoing operating results of the Company and a more useful comparison of year-over-year results. These non-GAAP measures supplement the Company's GAAP disclosures and should not be viewed as alternatives to GAAP measures of performance. Furthermore, such non-GAAP measures may not be consistent with similar measures provided or used by other companies. Non-GAAP measures included in this release are defined below. Reconciliations for these non-GAAP measures to GAAP are provided in the Selected Financial Information and Non-GAAP Measures section starting on page 11. Dow does not provide forward-looking GAAP financial measures or a reconciliation of forward-looking non-GAAP financial measures to the most comparable GAAP financial measures on a forward-looking basis because the Company is unable to predict with reasonable certainty the ultimate outcome of pending litigation, unusual gains and losses, foreign currency exchange gains or losses and potential future asset impairments, as well as discrete taxable events, without unreasonable effort. These items are uncertain, depend on various factors, and could have a material impact on GAAP results for the guidance period.

    Operating Earnings Per Share is defined as "Loss per common share - diluted" excluding the after-tax impact of significant items.

    Operating EBIT is defined as earnings (i.e., "Loss before income taxes") before interest, excluding the impact of significant items.

    Operating EBIT Margin is defined as Operating EBIT as a percentage of net sales.

    Operating EBITDA is defined as earnings (i.e., "Loss before income taxes") before interest, depreciation and amortization, excluding the impact of significant items.

    Free Cash Flow is defined as "Cash provided by (used for) operating activities - continuing operations," less capital expenditures. Under this definition, Free Cash Flow represents the cash generated by the Company from operations after investing in its asset base. Free Cash Flow, combined with cash balances and other sources of liquidity, represent the cash available to fund obligations and provide returns to shareholders. Free Cash Flow is an integral financial measure used in the Company's financial planning process.

    Cash Flow Conversion is defined as "Cash provided by (used for) operating activities - continuing operations," divided by Operating EBITDA. Management believes Cash Flow Conversion is an important financial metric as it helps the Company determine how efficiently it is converting its earnings into cash flow.

    Operating Return on Capital (ROC) is defined as net operating profit after tax, excluding the impact of significant items, divided by total average capital, also referred to as ROIC.

     

    Dow Inc. and Subsidiaries

    Consolidated Statements of Income



    In millions, except per share amounts (Unaudited)

    Three Months Ended

    Mar 31,

    2026

    Mar 31,

    2025

    Net sales

    $    9,794

    $   10,431

    Cost of sales

    9,154

    9,760

    Research and development expenses

    181

    200

    Selling, general and administrative expenses

    417

    366

    Amortization of intangibles

    46

    76

    Restructuring and asset related charges - net

    27

    208

    Equity in losses of nonconsolidated affiliates

    (303)

    (20)

    Sundry income (expense) - net

    121

    13

    Interest income

    42

    28

    Interest expense and amortization of debt discount

    219

    216

    Loss before income taxes

    (390)

    (374)

    Provision (credit) for income taxes

    55

    (84)

    Net loss

    (445)

    (290)

    Net income attributable to noncontrolling interests

    88

    17

    Net loss available for Dow Inc. common stockholders

    $      (533)

    $      (307)







    Per common share data:





    Loss per common share - basic

    $     (0.74)

    $     (0.44)

    Loss per common share - diluted

    $     (0.74)

    $     (0.44)







    Weighted-average common shares outstanding - basic

    721.2

    706.9

    Weighted-average common shares outstanding - diluted

    721.2

    706.9

     

    Dow Inc. and Subsidiaries

    Consolidated Balance Sheets



    In millions, except share amounts (Unaudited)

    Mar 31,

    2026

    Dec 31,

    2025

    Assets





    Current Assets





    Cash and cash equivalents (variable interest entities restricted - 2026: $259; 2025: $31)

    $         4,110

    $         3,816

    Accounts and notes receivable:





    Trade (net of allowance for doubtful receivables - 2026: $63; 2025: $59)

    5,185

    4,762

    Other

    2,224

    1,876

    Inventories

    6,775

    6,595

    Other current assets

    1,175

    1,013

    Total current assets (variable interest entities restricted - 2026: $465; 2025: $228)

    19,469

    18,062

    Investments





    Investment in nonconsolidated affiliates

    1,138

    1,264

    Other investments (investments carried at fair value - 2026: $2,236; 2025: $2,212)

    3,008

    3,017

    Noncurrent receivables

    444

    309

    Total investments

    4,590

    4,590

    Property





    Property

    66,017

    65,863

    Less: Accumulated depreciation

    43,909

    43,613

    Net property (variable interest entities restricted - 2026: $2,362; 2025: $2,385)

    22,108

    22,250

    Other Assets





    Goodwill

    7,947

    7,978

    Other intangible assets (net of accumulated amortization - 2026: $5,770; 2025: $5,727)

    1,426

    1,486

    Operating lease right-of-use assets

    1,426

    1,356

    Deferred income tax assets

    1,525

    1,511

    Deferred charges and other assets

    1,289

    1,305

    Total other assets (variable interest entities restricted - 2026: $220; 2025: $226)

    13,613

    13,636

    Total Assets

    $       59,780

    $       58,538

    Liabilities and Equity





    Current Liabilities





    Notes payable

    $             88

    $             90

    Long-term debt due within one year

    793

    222

    Accounts payable:





    Trade

    4,769

    4,151

    Other

    1,392

    1,394

    Operating lease liabilities - current

    348

    340

    Income taxes payable

    344

    337

    Accrued and other current liabilities

    2,802

    2,649

    Total current liabilities (variable interest entities nonrecourse - 2026: $451; 2025: $438)

    10,536

    9,183

    Long-Term Debt (variable interest entities nonrecourse - 2026: $184; 2025: $190)

    17,254

    17,849

    Other Noncurrent Liabilities





    Deferred income tax liabilities

    348

    364

    Pension and other postretirement benefits - noncurrent

    4,542

    4,694

    Asbestos-related liabilities - noncurrent

    602

    628

    Operating lease liabilities - noncurrent

    1,146

    1,097

    Other noncurrent obligations

    8,589

    7,201

    Total other noncurrent liabilities (variable interest entities nonrecourse - 2026: $350; 2025: $364)

    15,227

    13,984

    Stockholders' Equity





    Common stock (authorized 5,000,000,000 shares of $0.01 par value each;

    issued 2026: 791,896,099 shares; 2025: 790,287,565 shares)

    8

    8

    Additional paid-in capital

    11,062

    11,112

    Retained earnings

    15,992

    16,781

    Accumulated other comprehensive loss

    (7,698)

    (7,660)

    Treasury stock at cost (2026: 71,154,661 shares; 2025: 73,065,152 shares)

    (4,115)

    (4,233)

    Dow Inc.'s stockholders' equity

    15,249

    16,008

    Noncontrolling interests

    1,514

    1,514

    Total equity

    16,763

    17,522

    Total Liabilities and Equity

    $       59,780

    $       58,538

     

    Dow Inc. and Subsidiaries

    Consolidated Statements of Cash Flows



    In millions (Unaudited)

    Three Months Ended

    Mar 31,

    2026

    Mar 31,

    2025

    Operating Activities





    Net loss

    $         (445)

    $         (290)

    Adjustments to reconcile net loss to net cash provided by operating activities:





    Depreciation and amortization

    719

    714

    Credit for deferred income tax

    (48)

    (177)

    Earnings of nonconsolidated affiliates less than dividends received

    502

    133

    Net periodic pension benefit credit

    (8)

    (26)

    Pension contributions

    (41)

    (31)

    Net gain on sales of assets, businesses and investments

    (4)

    (2)

    Restructuring and asset related charges - net

    27

    208

    Other net (gain) loss

    (14)

    185

    Changes in assets and liabilities, net of effects of acquired and divested companies:





    Accounts and notes receivable

    (531)

    (301)

    Inventories

    (180)

    (221)

    Accounts payable

    551

    38

    Other assets and liabilities, net

    596

    (126)

    Cash provided by operating activities - continuing operations

    1,124

    104

    Cash provided by (used for) operating activities - discontinued operations

    —

    (13)

    Cash provided by operating activities

    1,124

    91

    Investing Activities





    Capital expenditures

    (503)

    (685)

    Proceeds from incentives related to capital expenditures

    40

    —

    Cash flow hedging related to capital expenditures

    3

    —

    Investment in gas field developments

    (21)

    (30)

    Proceeds from sales of property, businesses and consolidated companies, net of cash divested

    4

    3

    Investments in and loans to nonconsolidated affiliates

    —

    (3)

    Purchases of investments

    (331)

    (104)

    Proceeds from sales and maturities of investments

    319

    416

    Other investing activities, net

    41

    2

    Cash used for investing activities

    (448)

    (401)

    Financing Activities





    Changes in short-term notes payable

    —

    (1)

    Proceeds from issuance of short-term debt greater than three months

    4

    11

    Payments on short-term debt greater than three months

    (4)

    (6)

    Proceeds from issuance of long-term debt

    52

    1,013

    Payments on long-term debt

    (46)

    (957)

    Collections on securitization programs, net of remittances

    —

    15

    Transaction financing, debt issuance and other costs

    (1)

    (64)

    Employee taxes paid for share-based payment arrangements

    (14)

    (16)

    Distributions to noncontrolling interests

    (59)

    (22)

    Dividends paid to stockholders

    (252)

    (494)

    Cash used for financing activities

    (320)

    (521)

    Effect of exchange rate changes on cash, cash equivalents and restricted cash

    (73)

    123

    Summary





    Increase (decrease) in cash, cash equivalents and restricted cash

    283

    (708)

    Cash, cash equivalents and restricted cash at beginning of period

    3,952

    2,263

    Cash, cash equivalents and restricted cash at end of period

    $       4,235

    $       1,555

    Less: Restricted cash and cash equivalents, included in "Other current assets"

    125

    90

    Cash and cash equivalents at end of period

    $       4,110

    $       1,465

     

    Dow Inc. and Subsidiaries

    Net Sales by Segment and Geographic Region

     



    Net Sales by Segment

    Three Months Ended

    In millions (Unaudited)

    Mar 31,

    2026

    Mar 31,

    2025

    Packaging & Specialty Plastics

    $    4,919

    $    5,310

    Industrial Intermediates & Infrastructure

    2,626

    2,855

    Performance Materials & Coatings

    2,080

    2,071

    Corporate

    169

    195

    Total

    $    9,794

    $   10,431

    U.S. & Canada

    $    3,796

    $    4,227

    EMEAI 1

    3,184

    3,274

    Asia Pacific

    1,738

    1,858

    Latin America

    1,076

    1,072

    Total

    $    9,794

    $   10,431

     

    Net Sales Variance by Segment and Geographic Region

    Three Months Ended Mar 31,2026



    Local

    Price &

    Product

    Mix

    Currency

    Volume

    Total



    Percent change from prior year



    Packaging & Specialty Plastics

    (9) %

    3 %

    (1) %

    (7) %



    Industrial Intermediates & Infrastructure

    (8)

    4

    (4)

    (8)



    Performance Materials & Coatings

    (4)

    2

    2

    —



    Total

    (7) %

    3 %

    (2) %

    (6) %



    Total, excluding the Hydrocarbons & Energy business

    (7) %

    3 %

    — %

    (4) %



    U.S. & Canada

    (6) %

    — %

    (4) %

    (10) %



    EMEAI 1

    (9)

    8

    (2)

    (3)



    Asia Pacific

    (8)

    2

    —

    (6)



    Latin America

    (9)

    —

    9

    —



    Total

    (7) %

    3 %

    (2) %

    (6) %



    1. Europe, Middle East, Africa and India.

     

    Dow Inc. and Subsidiaries

    Selected Financial Information and Non-GAAP Measures

     



    Operating EBIT by Segment

    Three Months Ended

    In millions (Unaudited)

    Mar 31,

    2026

    Mar 31,

    2025

    Packaging & Specialty Plastics

    $       208

    $       342

    Industrial Intermediates & Infrastructure

    (118)

    (128)

    Performance Materials & Coatings

    117

    49

    Corporate

    (53)

    (33)

    Total

    $       154

    $       230







    Depreciation and Amortization by Segment

    Three Months Ended

    In millions (Unaudited)

    Mar 31,

    2026

    Mar 31,

    2025

    Packaging & Specialty Plastics

    $       382

    $       360

    Industrial Intermediates & Infrastructure

    148

    146

    Performance Materials & Coatings

    181

    200

    Corporate

    8

    8

    Total

    $       719

    $       714







    Operating EBITDA by Segment

    Three Months Ended

    In millions (Unaudited)

    Mar 31,

    2026

    Mar 31,

    2025

    Packaging & Specialty Plastics

    $       590

    $       702

    Industrial Intermediates & Infrastructure

    30

    18

    Performance Materials & Coatings

    298

    249

    Corporate

    (45)

    (25)

    Total

    $       873

    $       944







    Equity in Losses of Nonconsolidated Affiliates by Segment

    Three Months Ended

    In millions (Unaudited)

    Mar 31,

    2026

    Mar 31,

    2025

    Packaging & Specialty Plastics 1

    $        (63)

    $         39

    Industrial Intermediates & Infrastructure 1

    (242)

    (58)

    Performance Materials & Coatings

    1

    —

    Corporate

    1

    (1)

    Total

    $      (303)

    $        (20)







    Reconciliation of "Net loss" to "Operating EBIT"

    Three Months Ended

    In millions (Unaudited)

    Mar 31,

    2026

    Mar 31,

    2025

    Net loss

    $      (445)

    $      (290)

    + Provision (credit) for income taxes

    55

    (84)

    Loss before income taxes

    $      (390)

    $      (374)

    -  Interest income

    42

    28

    + Interest expense and amortization of debt discount

    219

    216

    -  Significant items

    (367)

    (416)

    Operating EBIT (non-GAAP)

    $       154

    $       230

    1. Packaging & Specialty Plastics and Industrial Intermediates & Infrastructure include losses of $81 million and $211 million, respectively, related to the Sadara guarantee liability adjustment, a significant item.

     

    Dow Inc. and Subsidiaries

    Selected Financial Information and Non-GAAP Measures



    Significant Items Impacting Results for the Three Months Ended Mar 31, 2026

    In millions, except per share amounts (Unaudited)

    Pretax 1

    Net 

    income

    (loss) 2

    EPS 3

    Income Statement Classification

    Reported results

    $    (390)

    $    (533)

    $   (0.74)



    Less: Significant items









    Transform to Outperform 4

    (80)

    (63)

    (0.09)

    SG&A ($53 million); Restructuring and

      asset related charges - net

      ($27 million)

    2025 Restructuring implementation

      costs 5

    (21)

    (17)

    (0.02)

    Cost of sales ($20 million);

     SG&A ($1 million)

    Sadara guarantee liability adjustment 6

    (292)

    (227)

    (0.31)

    Equity in losses of nonconsolidated

      affiliates

    Litigation related charges, awards and

      adjustments 7

    26

    21

    0.03

    Sundry income (expense) - net

    Income tax related items 8

    —

    (150)

    (0.21)

    Provision for income taxes

    Total significant items

    $    (367)

    $    (436)

    $   (0.60)



    Operating results (non-GAAP)

    $      (23)

    $      (97)

    $   (0.14)



     

    Significant Items Impacting Results for the Three Months Ended Mar 31, 2025

    In millions, except per share amounts (Unaudited)

    Pretax 1

    Net 

    income

    (loss) 2

    EPS 3

    Income Statement Classification

    Reported results

    $    (374)

    $    (307)

    $   (0.44)



    Less: Significant items









    Restructuring, implementation and

      efficiency costs, and asset related

      charges - net 9

    (51)

    (39)

    (0.05)

    Cost of sales ($44 million);

     R&D ($1 million); SG&A ($4 million);

     Restructuring and asset related

     charges - net ($1 million); Sundry

     income (expense) - net ($1 million)

    2025 Restructuring Program 10

    (207)

    (161)

    (0.23)

    Restructuring and asset related

     charges - net

    Loss on early extinguishment of debt

    (60)

    (48)

    (0.07)

    Sundry income (expense) - net

    Indemnification and other transaction

      related costs 11

    (98)

    (76)

    (0.11)

    Cost of Sales

     Total significant items

    $    (416)

    $    (324)

    $   (0.46)



    Operating results (non-GAAP)

    $       42

    $       17

    $     0.02



    1. "Loss before income taxes."
    2. "Net loss available for Dow Inc. common stockholders." The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
    3. "Losses per common share - diluted," which includes the impact of participating securities in accordance with the two-class method.
    4. Costs to achieve and severance and related benefit costs associated with Transform to Outperform.
    5. Implementation costs associated with the Company's 2025 Restructuring Program.
    6. Loss due to change in fair value of the estimated liability associated with the Company's guarantee of Sadara's project financing debt.
    7. Related to a gain associated with a legal matter with Nova Chemicals Corporation ("Nova").
    8. Related to tax expense associated with the legal matter with Nova.
    9. Restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program and impairment charges related to the write-down of certain manufacturing assets, partly offset by an asset related credit adjustment.
    10. Severance and related benefit costs associated with the Company's 2025 Restructuring Program.
    11. Includes a charge related to an arbitration settlement agreement for historical product claims from a divested business.

     

    Dow Inc. and Subsidiaries

    Selected Financial Information and Non-GAAP Measures



    Reconciliation of Free Cash Flow

    Three Months Ended

    In millions (Unaudited)

    Mar 31,

    2026

    Mar 31,

    2025

    Cash provided by operating activities - continuing operations (GAAP)

    $     1,124

    $        104

    Capital expenditures

    (503)

    (685)

    Free Cash Flow (non-GAAP)

    $        621

    $       (581)

     

    Reconciliation of Cash Flow Conversion

    Three Months Ended

    In millions (Unaudited)

    Jun 30,

    2025

    Sep 30,

    2025

    Dec 31,

    2025

    Mar 31,

    2026

    Cash provided by (used for) operating activities - continuing

      operations (GAAP)

    $    (470)

    $  1,130

    $     298

    $  1,124

    Net income (loss) (GAAP)

    $    (801)

    $     124

    $ (1,477)

    $    (445)

    Cash flow from operations to net income (GAAP) 1

    N/A

    911.3 %

    N/A

    N/A

    Cash flow from operations to net income - trailing twelve months

    (GAAP) 2



    N/A

    Operating EBITDA (non-GAAP)

    $     703

    $     868

    $     741

    $     873

    Cash Flow Conversion (Cash flow from operations to Operating

      EBITDA) (non-GAAP)

    (66.9) %

    130.2 %

    40.2 %

    128.8 %

    Cash Flow Conversion - trailing twelve months (non-GAAP)



    65.4 %

    1. Cash flow from operations to net income is not applicable for the second quarter and fourth quarter of 2025, and first quarter of 2026 due to a net loss for the period.
    2. Cash flow from operations to net income - trailing twelve months is not applicable due to a net loss for the trailing twelve months period.

     

    For further information, please contact:



    Investors:

    Andrew Riker

    [email protected]

    Media:

    Sarah Young

    [email protected]





    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/dow-reports-first-quarter-2026-results-302751593.html

    SOURCE The Dow Chemical Company

    Get the next $DOW alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DOW

    DatePrice TargetRatingAnalyst
    4/9/2026Neutral → Overweight
    Alembic Global Advisors
    4/6/2026$35.00Neutral → Underperform
    BofA Securities
    3/12/2026$40.00Neutral → Buy
    Citigroup
    3/9/2026$40.00Sector Perform → Outperform
    RBC Capital Mkts
    3/9/2026$37.00Hold → Buy
    Vertical Research
    3/6/2026$40.00Neutral → Overweight
    Analyst
    3/5/2026$35.00Underperform → Market Perform
    BMO Capital Markets
    3/4/2026$38.00Sector Weight → Overweight
    KeyBanc Capital Markets
    More analyst ratings

    $DOW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Dow upgraded by Alembic Global Advisors

    Alembic Global Advisors upgraded Dow from Neutral to Overweight

    4/9/26 8:22:22 AM ET
    $DOW
    Major Chemicals
    Industrials

    Dow downgraded by BofA Securities with a new price target

    BofA Securities downgraded Dow from Neutral to Underperform and set a new price target of $35.00

    4/6/26 8:41:55 AM ET
    $DOW
    Major Chemicals
    Industrials

    Dow upgraded by Citigroup with a new price target

    Citigroup upgraded Dow from Neutral to Buy and set a new price target of $40.00

    3/12/26 8:38:32 AM ET
    $DOW
    Major Chemicals
    Industrials

    $DOW
    SEC Filings

    View All

    Dow Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - DOW INC. (0001751788) (Filer)

    4/23/26 6:58:21 AM ET
    $DOW
    Major Chemicals
    Industrials

    Dow Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - DOW INC. (0001751788) (Filer)

    4/14/26 6:35:07 AM ET
    $DOW
    Major Chemicals
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by Dow Inc.

    SCHEDULE 13G/A - DOW INC. (0001751788) (Subject)

    3/26/26 6:04:49 PM ET
    $DOW
    Major Chemicals
    Industrials

    $DOW
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Dow reports first quarter 2026 results

    MIDLAND, Mich., April 23, 2026 /PRNewswire/ -- Dow (NYSE:DOW): FINANCIAL HIGHLIGHTSNet sales were $9.8 billion, down 6% year-over-year, reflecting flat sales in Performance Materials & Coatings and declines in the other operating segments.Volume decreased 2% year-over-year, driven by declines in Industrial Intermediates & Infrastructure, which was impacted by the Middle East conflict. Gains in Packaging & Specialty Plastics from higher polyethylene volumes were more than offset by lower merchant olefins sales following the idling of a cracker in Europe, the Middle East, Africa a

    4/23/26 6:00:00 AM ET
    $DOW
    Major Chemicals
    Industrials

    Dow Chair and CEO Jim Fitterling to Become Executive Chair; Karen S. Carter Appointed Chief Executive Officer

    MIDLAND, Mich., April 14, 2026 /PRNewswire/ -- Dow (NYSE:DOW) today announced that Jim Fitterling, Chair and Chief Executive Officer, will become Executive Chair of the Board, effective July 1, 2026. The Dow Board of Directors has appointed Karen S. Carter, currently Chief Operating Officer, as Chief Executive Officer, effective July 1, 2026. Carter will also join Dow's Board of Directors at that time. Richard Davis will continue to serve as Dow's Independent Lead Director. Today's announcement reflects the culmination of a multi-year, thoughtful succession planning process and

    4/14/26 6:30:00 AM ET
    $DOW
    Major Chemicals
    Industrials

    Dow announces results from 2026 Annual Stockholder Meeting

    All director nominees re-elected for one-year termsBoard declares quarterly dividend of 35 cents per shareMIDLAND, Mich., April 9, 2026 /PRNewswire/ -- Dow (NYSE: DOW) is pleased to report the results of its 2026 Annual Meeting of Stockholders. Today stockholders elected Samuel R. Allen, Gaurdie E. Banister Jr., Wesley G. Bush, Richard K. Davis, Jerri DeVard, Debra L. Dial, Jeff M. Fettig, Jim Fitterling, Jacqueline C. Hinman, Luis Alberto Moreno, Jill S. Wyant and Daniel W. Yohannes to the Company's Board of Directors for one-year terms. Biographies for all directors, committee

    4/9/26 4:15:00 PM ET
    $DOW
    Major Chemicals
    Industrials

    $DOW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Bush Wesley G

    4 - DOW INC. (0001751788) (Issuer)

    4/13/26 5:03:51 PM ET
    $DOW
    Major Chemicals
    Industrials

    SEC Form 4 filed by Davis Richard K

    4 - DOW INC. (0001751788) (Issuer)

    4/13/26 5:03:58 PM ET
    $DOW
    Major Chemicals
    Industrials

    SEC Form 4 filed by Hinman Jacqueline C.

    4 - DOW INC. (0001751788) (Issuer)

    4/13/26 5:03:44 PM ET
    $DOW
    Major Chemicals
    Industrials

    $DOW
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Dial Debra L. bought $26,197 worth of shares (675 units at $38.81) (SEC Form 4)

    4 - DOW INC. (0001751788) (Issuer)

    2/11/25 4:15:26 PM ET
    $DOW
    Major Chemicals
    Industrials

    Director Banister Gaurdie E. Jr. bought $299,932 worth of shares (7,339 units at $40.87) (SEC Form 4)

    4 - DOW INC. (0001751788) (Issuer)

    12/17/24 4:59:47 PM ET
    $DOW
    Major Chemicals
    Industrials

    Chair and CEO Fitterling James R bought $1,062,155 worth of shares (25,600 units at $41.49), increasing direct ownership by 11% to 117,837 units (SEC Form 4)

    4 - DOW INC. (0001751788) (Issuer)

    12/16/24 4:19:06 PM ET
    $DOW
    Major Chemicals
    Industrials

    $DOW
    Leadership Updates

    Live Leadership Updates

    View All

    Dow announces results from 2026 Annual Stockholder Meeting

    All director nominees re-elected for one-year termsBoard declares quarterly dividend of 35 cents per shareMIDLAND, Mich., April 9, 2026 /PRNewswire/ -- Dow (NYSE: DOW) is pleased to report the results of its 2026 Annual Meeting of Stockholders. Today stockholders elected Samuel R. Allen, Gaurdie E. Banister Jr., Wesley G. Bush, Richard K. Davis, Jerri DeVard, Debra L. Dial, Jeff M. Fettig, Jim Fitterling, Jacqueline C. Hinman, Luis Alberto Moreno, Jill S. Wyant and Daniel W. Yohannes to the Company's Board of Directors for one-year terms. Biographies for all directors, committee

    4/9/26 4:15:00 PM ET
    $DOW
    Major Chemicals
    Industrials

    Dow to participate at the 2026 J.P. Morgan Industrials Conference

    MIDLAND, Mich., March 16, 2026 /PRNewswire/ -- Dow Inc. (NYSE: DOW) will participate in a fireside chat during the 2026 J.P. Morgan Industrials Conference on Wednesday, March 18 at 8:45 a.m. ET. Dow invites investors to join the live webcast through its website. A replay and transcript will also be available following the event.About DowDow (NYSE:DOW) is one of the world's leading materials science companies, serving customers in high-growth markets such as packaging, infrastructure, mobility and consumer applications. Our global breadth, asset integration and scale, customer-fo

    3/16/26 8:05:00 AM ET
    $DOW
    Major Chemicals
    Industrials

    Valtris Specialty Chemicals Announces New Chief Executive Officer

    Industry veteran Mike McGaugh appointed Valtris Specialty Chemicals ("Valtris"), a leading global manufacturer of a comprehensive portfolio of specialty additives, announced today the appointment of Mike McGaugh as the company's new Chief Executive Officer. Mr. McGaugh has assumed the role held by former CEO, Simon Medley, who will be retiring as part of this transition but will continue to advise the company. Valtris is a portfolio company of SK Capital. "We are thrilled to welcome Mike, an industry veteran with a proven track record in the chemical and materials industries," said Jack Norris, a Managing Director of SK Capital. "Mike's decades of demonstrated leadership experience and

    1/13/26 6:30:00 AM ET
    $DOW
    $MYE
    Major Chemicals
    Industrials
    Plastic Products

    $DOW
    Financials

    Live finance-specific insights

    View All

    Dow reports first quarter 2026 results

    MIDLAND, Mich., April 23, 2026 /PRNewswire/ -- Dow (NYSE:DOW): FINANCIAL HIGHLIGHTSNet sales were $9.8 billion, down 6% year-over-year, reflecting flat sales in Performance Materials & Coatings and declines in the other operating segments.Volume decreased 2% year-over-year, driven by declines in Industrial Intermediates & Infrastructure, which was impacted by the Middle East conflict. Gains in Packaging & Specialty Plastics from higher polyethylene volumes were more than offset by lower merchant olefins sales following the idling of a cracker in Europe, the Middle East, Africa a

    4/23/26 6:00:00 AM ET
    $DOW
    Major Chemicals
    Industrials

    Dow declares quarterly dividend of 35 cents per share

    MIDLAND, Mich., Feb. 12, 2026 /PRNewswire/ -- Dow (NYSE:DOW) has declared a dividend of 35 cents per share, payable March 13, 2026, to shareholders of record on February 27, 2026. This marks the 458th consecutive dividend paid by the Company or its affiliates since 1912. About DowDow (NYSE:DOW) is one of the world's leading materials science companies, serving customers in high-growth markets such as packaging, infrastructure, mobility and consumer applications. Our global breadth, asset integration and scale, customer-focused innovation and leading business positions enable u

    2/12/26 4:15:00 PM ET
    $DOW
    Major Chemicals
    Industrials

    Dow reports fourth quarter 2025 results

    MIDLAND, Mich., Jan. 29, 2026 /PRNewswire/ -- Dow (NYSE:DOW): FINANCIAL HIGHLIGHTS Net sales were $9.5 billion, down 9% year-over-year, reflecting declines in all operating segments. Sequentially, net sales were down 5%, led by local price and volume declines from normal seasonality.Volume decreased 2% year-over-year, led by declines in Packaging & Specialty Plastics, driven by lower merchant olefins sales in Europe, the Middle East, Africa and India (EMEAI) following the idling of a cracker in the region earlier in the year. Sequentially, volume decreased 2%, led by normal se

    1/29/26 6:00:00 AM ET
    $DOW
    Major Chemicals
    Industrials

    $DOW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Dow Inc.

    SC 13G/A - DOW INC. (0001751788) (Subject)

    11/12/24 2:25:16 PM ET
    $DOW
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Dow Inc.

    SC 13G/A - DOW INC. (0001751788) (Subject)

    11/4/24 11:51:32 AM ET
    $DOW
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Dow Inc.

    SC 13G/A - DOW INC. (0001751788) (Subject)

    10/17/24 12:57:12 PM ET
    $DOW
    Major Chemicals
    Industrials